Erica Jaein Lee, MD

Professionally, I am highly motivated and dedicated to making significant contributions to advancing Neuroradiology research and practice. Specifically, I have developed a special focus on neurological molecular imaging, with an emphasis on the advancement of brain PET/MRI and hybrid imaging techniques in dementia and neurodegenerative disease. I was awarded the Foundation of the ASNR 2021 Boerger Research Fund for Alzheimer s Disease and Neurocognitive Disorders for the project [18F] PI-2620 in Primary Progressive Aphasia (Franceschi AM, PI), with the goal of characterizing biodistribution of abnormal tau accumulation in PPA subtypes using the novel second generation tracer PI-2620 and correlating these findings with clinical disease severity and neurodegeneration. I am also PI for the project Utility of [18F] PI-2620 as Universal Biomarker for the A/T/N Classification of Dementia and Neurodegenerative Disease , which aims to establish the efficacy of PI-2620 as a single, universal biomarker for the A/T/N classification scheme of dementia, with the eventual goal of its use in descriptive classification, patient selection and target engagement assessment in disease-modifying clinical treatment trials. I contribute as a co-Investigator on the study A Life Course Approach to Integrating Trauma and Cognitive Aging: A Cohort of 9/11 Responders, which is part of the World Trade Center (WTC) responders aging program (NIH R01 AG049953; Clouston, PI). This research focuses on PTSD and WTC exposures as risk factors for cognitive dysfunction and decline in a prospective cohort of responders, alongside changes in -amyloid, tau deposition, and neurodegeneration. These varied experiences have allowed me to understand the characterization of non-Alzheimer s tauopathies, and have improved my analytical expertise to apply this knowledge to studying Alzheimer s disease and related neurocognitive disorders. In addition to multiple scientific publications on these topics, I am lead editor of the textbook Hybrid PET/MR Neuroimaging: A Comprehensive Approach (Springer Nature, 2022).

Viera Lakticova, MD, is a distinguished medical practice situated in the vibrant city of New York, NY. Known for their dedication to patient well-being, this facility offers a range of healthcare services aimed at enhancing the overall health and vitality of individuals in the community. With a focus on personalized care, Viera Lakticova, MD, specializes in providing top-notch medical treatments, preventative care, and expert consultations to address a variety of health concerns. At Viera Lakticova, MD, patients can expect to receive exceptional medical attention from a team of skilled professionals who are committed to upholding the highest standards of healthcare excellence. From routine check-ups to specialized treatments, this practice strives to promote a culture of wellness and compassion in every aspect of their patient care. By staying abreast of the latest medical advancements and fostering a supportive environment, Viera Lakticova, MD, stands as a beacon of quality healthcare in the bustling city of New York. Generated using this brand's available information

Suhail Raoof, MD, in New York, NY, is a medical practice dedicated to providing personalized healthcare services to patients in the bustling urban landscape. Specializing in a diverse range of medical fields, this establishment offers primary care, specialized treatments, surgical interventions, and diagnostic procedures to address the unique needs of each individual seeking medical attention. With a focus on patient well-being and healthcare excellence, Suhail Raoof, MD, combines clinical expertise with a compassionate approach to medical care. Their team of skilled professionals is actively engaged in medical research, educational endeavors, and community health projects, reflecting a commitment to enhancing healthcare practices and outcomes for the diverse population they serve in the vibrant city of New York. Generated using this brand's available information